Serum adenosine deaminase (ADA) activities and neopterine levels during therapy in patients with pulmonary tuberculosis and community-acquired pneumonia

R. Gelisgen, H. Uzun, F. Erdenen, O. Kar, O. Tabak, G. Camsari, B. Ozdemir (Istanbul, Turkey)

Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Session: What is new in the diagnosis of tuberculosis?
Session type: Thematic Poster Session
Number: 4994
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Gelisgen, H. Uzun, F. Erdenen, O. Kar, O. Tabak, G. Camsari, B. Ozdemir (Istanbul, Turkey). Serum adenosine deaminase (ADA) activities and neopterine levels during therapy in patients with pulmonary tuberculosis and community-acquired pneumonia. Eur Respir J 2010; 36: Suppl. 54, 4994

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between levels of serum adenosin deaminase (ADA) and sputum smear conversion in patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 425s
Year: 2004

Pleural fluid and serum adenosine deaminase (ADA) activities reflects the severity of lung tuberculosis
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008

The worth of serum adenosine deaminase levels in patients with pulmonary tuberculosis for follow-up the disease
Source: Eur Respir J 2004; 24: Suppl. 48, 425s
Year: 2004

Activity of lysozyme and adenosine deaminase in patients with pulmonary tuberculosis
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018

Adenosine deaminase in the COPD pathogenesis in patients with pulmonary tuberculosis
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018


Serum KL-6 level is increased in patients with pneumocystis pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 101s
Year: 2006

Adenosine deaminase level in the diagnosis of tuberculosis pleural effusions- a study of 205 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 425s
Year: 2004

Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011

Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 176s
Year: 2003

High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010


Serum levels of IL-6 in severe community-acquired pneumonia
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010

The discriminatory value of procalcitonin (PCT) and C-reactive protein (CRP) levels in HIV-seropositive patients presenting with community acquired pneumonia (CAP) due to pulmonary tuberculosis (PTB) compared with patients with pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004

Adenosine deaminase (ADA), interferon-gamma (IFN-gamma) and interleukin-18 (IL-18) levels in pleural fluid and sera for the diagnosis of tuberculous pleuritis
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008

Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 453s
Year: 2005

Serum IFN-γ and TNF-α levels in pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005

Serum procalcitonine (PCT) as a marker of respiratory infection by pseudomonas aeruginosa (PA) in patients with COPD or bronchiectasis
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009


Glutathione level in community-acquired pneumonia patients.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Pleural effusion adenosine deaminase (ADA) level in patients with tuberculous pleurisy
Source: Annual Congress 2010 - Extrapulmonary tuberculosis
Year: 2010

Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia
Source: Eur Respir J 2008; 32: 726-732
Year: 2008



C-reactive protein as severity biomarker in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 545s
Year: 2005